Feb 6, 2016 by Brian FeroldiWhy Share of Novavax Inc Dropped 34% in JanuaryNovavax's shares couldn't sidestep the month's biotech beatdown.
Feb 6, 2016 by Brian FeroldiWhy Halozyme Therapeutics Inc Plunged 51% in JanuaryIt was a rough month for the human-enzyme specialist.
Feb 5, 2016 by Brian FeroldiThe Key Takeaways From Alexion Pharmaceuticals Inc.'s Earnings ReleaseAlexion Pharmaceuticals released its fourth-quarter and full-year earnings earlier today. Here are the key numbers that investors need to know.
Feb 5, 2016 by Brian Feroldi3 Things to Look for in Regeneron Pharmaceuticals Inc.'s EarningsFrom Eylea sales to the late-stage pipeline, here are the three areas this Fool will be watching in Regeneron's fourth-quarter report.
Feb 5, 2016 by Brian FeroldiWhat to Expect When CVS Health Inc ReportsFrom acquisition integration to full-year guidance, here are the areas investors should pay attention to when this company reports its fourth-quarter results.
Feb 3, 2016 by Brian FeroldiForget Gilead Sciences: These Stocks Doubled Last YearInterested in stocks with huge growth potential? These three stocks hold promise for big gains in the years ahead.
Feb 3, 2016 by Brian FeroldiInstant Analysis: Gilead Sciences Raises Its Dividend 10%Putting more cash directly into shareholders' pockets.
Feb 2, 2016 by Brian FeroldiHow to Use a Stock Market Crash to Your AdvantageStocks are down big since the start of the year, but here's a list of three stocks you can safely buy in the market's carnage.
Feb 2, 2016 by Brian FeroldiIgnore Regeneron Pharmaceuticals, Inc: Here Are 3 Better Buys Right NowThinking about investing in Regeneron? Here are three names you might want to consider instead.
Feb 1, 2016 by Brian Feroldi, Selena Maranjian, and Sean Williams3 Biotech Stocks You Don't Have to BabysitAre you interested in biotech stocks that don't require you to follow their every move? Our contributors think you should put these three biotech stocks on your radar.
Feb 1, 2016 by Brian FeroldiWill 2016 Be Alexion Pharmaceuticals Inc.'s Best Year Yet?With two new drugs launching and a pipeline full of potential, the odds look good that the answer is yes.
Jan 30, 2016 by Brian FeroldiLast Week's Best Healthcare ETFHealthcare stocks had another rough week, but this healthcare ETF held up best.
Jan 30, 2016 by Brian FeroldiNetSuite Inc. Continues to Prove That Cloud Computing Is the FutureShares of the cloud-based software provider jumped on a better-than-expected earnings report.
Jan 29, 2016 by Brian FeroldiSkyworks Solutions Inc. Manufactures Another Solid QuarterManagement delivers double-digit revenue and earnings growth yet again.
Jan 29, 2016 by Brian FeroldiInstant Analysis: Gilead Sciences Inc.'s Longtime CEO Steps DownIt's a double dose of bummer news for shareholders today.
Jan 28, 2016 by Brian FeroldiWhy Abbott Laboratories Is Getting Crushed TodayA mixed earnings report and disappointing guidance cause shares to take a step back.
Jan 28, 2016 by Brian FeroldiCullen/Frost Bankers' Energy Exposure Causes Profits to FallThe Texas-based bank's exposure to the energy sector takes its toll on the company's profitability.
Jan 27, 2016 by Brian Feroldi, Selena Maranjian, and Sean Williams3 Healthcare Stocks You Don't Have to BabysitOn the hunt for a healthcare-related stock that doesn't require constant monitoring? Give these 3 stocks a look.
Jan 27, 2016 by Brian FeroldiWhy MannKind Corporation's Shares Are Skyrocketing TodayA report from Reuters says that the inhaled insulin maker is looking to sell itself, which has sent shares higher.
Jan 27, 2016 by Brian Feroldi, Selena Maranjian, and Matt Frankel, CFP3 Top Stocks for Retirees to BuyRetirees should look for companies with low risk, good growth, and stable income. Here are three to consider.
